Virtus ETF Advisers’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $428K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $47K | Sell |
|
|||||
|
2021
Q4 | $156K | Buy |
|
|||||
|
2021
Q3 | $168K | Sell |
|
|||||
|
2021
Q2 | $232K | Sell |
|
|||||
|
2021
Q1 | $320K | Buy |
|
|||||
|
2020
Q4 | $260K | Buy |
|
|||||
|
2020
Q3 | $69K | Sell |
|
|||||
|
2020
Q2 | $425K | Sell |
|
|||||
|
2020
Q1 | $427K | Sell |
|
|||||
|
2019
Q4 | $407K | Buy |
|
|||||
|
2019
Q3 | $242K | Sell |
|
|||||
|
2019
Q2 | $315K | Buy |
|
|||||
|
2019
Q1 | $274K | Sell |
|
|||||
|
2018
Q4 | $211K | Sell |
|
|||||
|
2018
Q3 | $371K | Sell |
|
|||||
|
2018
Q2 | $723K | Buy |
|
|||||
|
2018
Q1 | $481K | Buy |
|
|||||
|
2017
Q4 | $349K | Buy |
|
|||||
|
2017
Q3 | $453K | Buy |
|
|||||
|
2017
Q2 | $301K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $268K | Hold |
|
|||||
|
2016
Q2 | $221K | Buy |
|
|||||
|
2016
Q1 | $193K | Buy |
|